Dried Blood-Based Protein Profiling Using Antibody Arrays.

Area of Science:

• Biomedical Engineering
• Clinical Chemistry
• Analytical Chemistry

Background:

• Dried blood spots (DBS) are gaining traction for clinical applications due to ease of collection.
• Traditional DBS use faces limitations including small sample volumes, area bias, homogeneity issues, and complex sample preparation.
• Existing immunoassay methods often require large sample volumes and specialized expertise, hindering widespread clinical adoption.

Purpose of the Study:

• To highlight the advantages of antibody array technology for dried blood spot analysis.
• To address the limitations associated with traditional dried blood spot utility in clinical settings.
• To present antibody arrays as a solution for sensitive, reproducible, and cost-effective dried blood spot clinical assessment.

Main Methods:

• Review of recent advances in antibody array technology.
• Comparison of antibody array performance with traditional immunoassay and mass spectrometry approaches.
• Evaluation of antibody arrays for overcoming DBS-specific challenges such as sample volume and homogeneity.

Main Results:

• Antibody array technology significantly increases multiplexing capabilities for DBS analysis.
• This technology reduces the required sample volume compared to conventional methods.
• It minimizes the expense and technical expertise needed for high-density approaches like mass spectrometry.

Conclusions:

• Antibody array technology offers a promising solution to enhance the clinical utility of dried blood spots.
• These arrays overcome key limitations of DBS, enabling more sensitive and reproducible clinical assessments.
• The advancements facilitate broader adoption of DBS in clinical diagnostics by reducing costs and complexity.